Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants

Neonatal diabetes mellitus (NDM) is a rare genetic disease characterized by severe hyperglycemia requiring insulin therapy with onset mostly within the first 6 months and rarely between 6-12 months of age. The disease can be classified into transient (TNDM) or permanent neonatal diabetes mellitus (P...

Full description

Bibliographic Details

Main Authors:	Valentina Mancioppi, Erica Pozzi, Sara Zanetta, Anna Missineo, Silvia Savastio, Fabrizio Barbetti, Simona Mellone, Mara Giordano, Ivana Rabbone
Format:	Artigo
Language:	Inglês
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Endocrinology
Subjects:	neonatal diabetes mellitus (NDM) monogenic diabetes KCNJ11 continuous subcutaneous insulin infusion (CSII) glibenclamide hyperglycemia
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1143736/full
Tags:	Add Tag No Tags, Be the first to tag this record!